Sign in
4

Changes in Ownership

Korro Bio, Inc. Filed Acc 0001127602-23-021561

Chief Scientific Officer sold 2,717 shares at an average $0.50 ($1,346)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Loose Christopher R. Chief Scientific Officer 2023-07-27 Sale 10b5-1 −1,373 $0.53 $728 184,994 D: show line 1 in the form
Loose Christopher R. Chief Scientific Officer 2023-07-28 Sale 10b5-1 −1,344 $0.46 $618 183,650 D: show line 2 in the form
Open-market sales · 2,717 sh · avg $0.50 · $1,346
Loading xslF345X05/form4.xml…